Chirality Emerges as Key Issue in Pharmaceutical Research

Abstract

RETURN TO ISSUEPREVNewsNEXTChirality Emerges as Key Issue in Pharmaceutical ResearchDespite concerns that complexities associated with racemate use could force drastic changes in the way chiral drugs are developed and marketed, many now believe upcoming regulations are unlikely to be draconianSTU BORMANView Author Information C&EN WashingtonCite this: Chem. Eng. News 1990, 68, 28, 9–14Publication Date (Print):July 9, 1990Publication History Published online10 November 2010Published inissue 9 July 1990https://doi.org/10.1021/cen-v068n028.p009Copyright © 1990 American Chemical SocietyArticle Views24Altmetric-Citations32LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InReddit PDF (2 MB) SUBJECTS:Molecular structure,Pharmaceuticals Get e-Alerts